PDE5 inhibitors for cystic fibrosis: can they also enhance chloride transport?

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.6, 2008-06, pp. : 965-968

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PDE5 Inhibitors and their Applications

Current Medicinal Chemistry, Vol. 17, Iss. 24, 2010-08 ,pp. : 2564-2587

Bentham Science Publishers

Access to resources Recommend Favorite

CFTR Chloride Channel Drug Discovery - Inhibitors as Antidiarrheals and Activators for Therapy of Cystic Fibrosis

Current Pharmaceutical Design, Vol. 12, Iss. 18, 2006-06 ,pp. : 2235-2247

Bentham Science Publishers

Access to resources Recommend Favorite

Alleviation of post-radical prostatectomy cavernosal fibrosis: future directions and potential utility for PDE5 inhibitors

By El-Sakka Ahmed I

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1305-1309

Informa Healthcare

Access to resources Recommend Favorite

PDE-5 Inhibitors: Clinical Points

Current Drug Targets, Vol. 16, Iss. 5, 2015-05 ,pp. : 420-426

Bentham Science Publishers

Access to resources Recommend Favorite

PDE5 Inhibitors in the Treatment of LUTS

Current Pharmaceutical Design, Vol. 15, Iss. 30, 2009-10 ,pp. : 3502-3505

Bentham Science Publishers

Access to resources Recommend Favorite